AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
METHYLPREDNISOLONE ACETATE
6 registrations across 3 African markets— 4 active
Markets with METHYLPREDNISOLONE ACETATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Epizolone Depot 40 mg/ ml Vial Suspension For Injection | 🇰🇪Kenya | Egyptian International Pharmaceutical Industries… | active | Mar 2030 |
| DEPO - MEDROL (1ML) INJECTABLE; INJECTION | 🇿🇼Zimbabwe | PFIZER LABORATORIES (PTY) LTD | active | Dec 2027 |
| DEPO MEDROL INJECTABLE; INJECTION | 🇿🇼Zimbabwe | PHARMACIA & UPJOHN | active | Dec 2027 |
| DEPO-MEDROL (2ML) INJECTABLE; INJECTION | 🇿🇼Zimbabwe | PFIZER LABORATORIES (PTY) LTD | active | Dec 2027 |
| DEPO-MEDROL 40MG/ML AQUEOUS SUSPENSION AQUEOUS SUSPENSION | 🇲🇼Malawi | — | expired | Mar 2024 |
| DEPO-MEDROL 40MG/ML AQUEOUS SUSPENSION AQUEOUS SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2003 |
METHYLPREDNISOLONE ACETATE in Africa — Regulatory Overview
METHYLPREDNISOLONE ACETATE is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Malawi, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 4 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.